BioMark Diagnostics Advanced Raman Spectrometer Could Potentially Serve as Complementary Detection Tool for COVID -19 / Coronavirus
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a developer of proprietary, non-invasive, and accurate diagnostic solutions which can help detect, monitor and assess cancer early and cost effectively, announced today following their annual technology meeting that their Advanced Raman Spectrometer might have potential to be modified and reconfigured for use in the detection of certain pathogens and mutations within the COVID-19, Coronavirus. BioMark's Raman Spectrometer...
2020-03-16 8:30 AM EDT